A 6-month-old female scarlet macaw (Ara macao) was presented after a 2-month period of anorexia and weakness. The bird was reluctant to fly one week before referral due to a painful left wing. Physical examination revealed a firm swelling around the left shoulder. Computer Tomography revealed an osteolytic process, suggestive of a bone tumor, affecting the left scapula ( Figs. 1 and 2) . Results of a biopsy of the mass suggested a giant cell tumor. The left wing, including the scapula, was amputated. The bird showed a fast recovery but died one hour later. The shoulder process was characterized as a giant cell tumor. To our knowledge this is the first complete report of a giant cell tumor of the bone in a bird.
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Giant cell tumor of bone (GCT) is a rare benign lesion that commonly occurs in the third and fourth decade of life. Giant cell tumors can be classified according to the Enneking staging system for benign bone tumors: stage 1, a latent lesion that is biologically stable; stage 2, an active, slow growing lesion which is confined within the bone; stage 3, locally aggressive with soft tissue extension. In humans the treatment of choice for patients with resectable tumors is surgery. Stage 1 GCT can be treated successfully with intralesional curettage. Stages 2 and 3, recurrent lesions or GCT of non-salvageable bones can be treated with wide resection and reconstruction. Radiotherapy is also an option in cases where complete excision or curettage cannot be performed (tumors of spine or sacrum) or for aggressive (lung metastasis) or multiply recurrent GCT (7).
In domestic animals, benign giant cell tumor (GCT) is a rare primary neoplasm. It has been described in cats in the tibia, femur, ulna and radius; it has also been described in the humerus of a dog. In veterinary medicine, there is a lack of information about the clinical and pathological aspects of GCT due to the small amount of cases described. This paper reports the first complete description of a giant cell tumor of the bone in an avian species.
In humans, benign giant cell tumor is a rare osteolytic tumor that occurs mainly in young adults and is typified by numerous characteristic large giant cells. GCT exhibits also an slightly female predilection. The progression of the tumor is chronic and symptoms are constant. Chronic pain in the region of the affected joint is worse at night and after activity. Decreased range of motion occurs late in the disease, as the tumor expands and distorts the end of the bone. The joint is normally not invaded. The bone will progressively expand to one side and overlying skin is stretched. Pathological fracture can occur late in the course of the disease when the cortical bone is destroyed.
The radiographic characteristics of giant cell tumor of bone in humans are circumscribed radiolucent area in the epiphysis extending to the metaphysis, outward expansion and thinning of the cortex, absence of periosteal bone formation, multiple bone septae, cortical fractures, and rarely extension of the tumor in the joint.
In this case, the GCT was located in the diaphysis of the left scapula extending to the articular cartilage without new bone formation. The bone destruction was so extensive that it was difficult to identify the origin of the lesion, i.e., methaphysis or diaphysis. Based on radiographic and CT findings the tumor can be considered a stage 3 lesion according to the classification from Enneking (locally aggressive with soft tissue extension).
The cause of death in our patient was attributed to hypovolemic shock probably due to the amount of blood lost during the surgery. Instead of surgery, intralesional curettage with adjuvant therapies like phenol, polymethylmetracrylate, liquid nitrogen and argon beam laser has been described for the treatment of GCT in humans. Unfortunately, intralesional curettage in humans has a high recurrence rate of 8-12% and adjuvant therapies have not yet been described for the treatment of bone tumors in avian species. Giant cell tumor in macaw
